Health Products

Sandoz-Valsartan Product Recall (2021-05-27)

May 27, 2021 · Published by Health Canada · Official notice

Alert type: Drug Recall

Category: Drugs

Issue: Product Safety

Audience: General Public, Healthcare Professionals, Hospitals

Department: Health Canada

Hazard classification: Type I

Sandoz Valsartan 80mg Tablet

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

CA$3.99/mo · cancel anytime

Lot or serial number	Companies	Brand name	DIN, NPN, DIN-HIM	Dosage form	Strength
KT9598	Recalling Firm Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA	B. Sandoz Valsartan 160mg Tablet	DIN 02356767	Tablet	Valsartan 160mg
KT8923, KV6185	Recalling Firm Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA	C. Sandoz Valsartan 320mg Tablet	DIN 02356775	Tablet	Valsartan 320mg
KT7180, KT9515	Recalling Firm Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA Marketing Authorization Holder Sandoz Canada Inc 110 de Lauzon Boucherville J4B 1E6 Quebec CANADA	A. Sandoz Valsartan 80mg Tablet	DIN 02356759	Tablet	Valsartan 80mg

Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.

Retailers

CA$3.99/mo · cancel anytime